Status:

UNKNOWN

Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Conditions:

Sarcoma, Soft Tissue

Osteosarcoma Tumor

Eligibility:

All Genders

7-25 years

Phase:

NA

Brief Summary

The aim of the proposed project is to study the long-term impact of adjuvant systemic multi- agent chemotherapy (cisplatin, anthracyclines, vincristine, methotrexate, alkylating agents) in survivors (...

Detailed Description

The aim of the proposed project is to study the long-term impact of adjuvant systemic multi- agent chemotherapy (cisplatin, anthracyclines, vincristine, methotrexate, alkylating agents) in survivors (...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Survivors of paediatric bone or soft tissue sarcomas, who were treated from 1992 onwards in the paediatric haematooncology department of UZLeuven according to one of the following treatment protocols.
  • \*For soft tissue sarcomas: MMT 95, MMT 98, RMS2005 or NRST2005
  • \*For Ewing sarcoma: EICESS 92, Euro-Ewing 99 or Euro-Ewing 2008
  • \*For osteosarcoma: EORTC 80931 or Euramos1 protocols
  • There will be variability in treatment regimens, but the patient group will be clustered into four subgroups:
  • Cisplatin and anthracyclines
  • Cisplatin, anthracyclines and methotrexate
  • Alkylating agents
  • Alkylating agents and anthracyclines
  • Exclusion criteria:
  • Mental retardation documented before treatment
  • Inability to perform the tests because of motor or sensory deficits
  • Epilepsy
  • Other cognitive disorders
  • Depression
  • Relapse
  • Parameningeal or intracranial sarcomas
  • Syndrome (e.g. Down)
  • Autologous stemcell transplantation
  • Head/neck/spinal radiotherapy or psychopharmaca

Exclusion

    Key Trial Info

    Start Date :

    December 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2018

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT02309242

    Start Date

    December 1 2014

    End Date

    October 1 2018

    Last Update

    August 21 2015

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UZ Leuven , pediatric oncology

    Leuven, Vl Brabant, Belgium, 3000